ABSTRACTPseudomonas aeruginosathrives in multiple environments and is capable of causing life-threatening infections in immunocompromised patients. RsmA is a posttranscriptional regulator that controls virulence factor production and biofilm formation. In this study, we investigated the expression and activity ofrsmAand the protein that it encodes, RsmA, inP. aeruginosamucAmutant strains, which are common in chronic infections. We determined that AlgU regulates a previously unknownrsmApromoter inP. aeruginosa. Western blot analysis confirmed that AlgU controlsrsmAexpression in both a laboratory strain and a clinical isolate. RNase protection assays confirmed the presence of tworsmAtranscripts and suggest that RpoS and AlgU regulatersmAexpression. Due to the increased amounts of RsmA inmucAmutant strains, a translational leader fusion of the RsmA target,tssA1, was constructed and tested inmucA,algU,retS,gacA, andrsmAmutant backgrounds to examine posttranscriptional activity. From these studies, we determined that RsmA is active inmucA22mutants, suggesting a role for RsmA inmucAmutant strains. Taken together, we have demonstrated that AlgU controlsrsmAtranscription and is responsible for RsmA activity inmucAmutant strains. We propose that RsmA is active inP. aeruginosamucAmutant strains and that RsmA also plays a role in chronic infections.IMPORTANCEP. aeruginosacauses severe infections in immunocompromised patients. The posttranscriptional regulator RsmA is known to control virulence and biofilm formation. We identify a newrsmApromoter and determine that AlgU is important in the control ofrsmAexpression. MutantmucAstrains that are considered mucoid were used to confirm increasedrsmAexpression from the AlgU promoter. We demonstrate, for the first time, that there is RsmA activity in mucoidP. aeruginosastrains. Our work suggests that RsmA may play a role during chronic infections as well as acute infections.